STATE STREET CORP - MEREO BIOPHARMA GROUP PLC ownership

MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 74 filers reported holding MEREO BIOPHARMA GROUP PLC in Q4 2021. The put-call ratio across all filers is 4.68 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of MEREO BIOPHARMA GROUP PLC
ValueSharesWeighting
Q1 2022$458,000
-30.6%
412,7680.0%0.00%
Q4 2021$660,000
-34.2%
412,7680.0%0.00%
Q3 2021$1,003,000
+304.4%
412,768
+427.8%
0.00%
Q2 2021$248,000
+359.3%
78,200
+373.5%
0.00%
Q4 2019$54,000
+12.5%
16,5160.0%0.00%
Q3 2019$48,000
+20.0%
16,5160.0%0.00%
Q2 2019$40,00016,5160.00%
Other shareholders
MEREO BIOPHARMA GROUP PLC shareholders Q4 2021
NameSharesValueWeighting ↓
Rubric Capital Management LP 16,756,120$18,767,0000.99%
Clearline Capital LP 3,058,596$3,426,0000.44%
SUVRETTA CAPITAL MANAGEMENT, LLC 9,142,067$10,239,0000.39%
DAFNA Capital Management LLC 1,096,513$1,228,0000.34%
Octagon Capital Advisors LP 1,000,000$1,120,0000.30%
Rock Springs Capital Management LP 6,230,275$6,978,0000.20%
Boxer Capital, LLC 2,250,000$2,520,0000.16%
Orbimed Advisors 7,109,954$7,963,0000.14%
Artal Group S.A. 1,500,000$1,680,0000.09%
SECTORAL ASSET MANAGEMENT INC 385,000$431,0000.09%
View complete list of MEREO BIOPHARMA GROUP PLC shareholders